- Home
- HUBC vs RDHL Comparison
HUBC vs RDHL Comparison
Compare HUBC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBC
- RDHL
- Stock Information
- Founded
- HUBC 2017
- RDHL 2009
- Country
- HUBC Israel
- RDHL Israel
- Employees
- HUBC N/A
- RDHL N/A
- Industry
- HUBC
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- HUBC
- RDHL Health Care
- Exchange
- HUBC Nasdaq
- RDHL Nasdaq
- Market Cap
- HUBC 19.3M
- RDHL 4.3M
- IPO Year
- HUBC N/A
- RDHL N/A
- Fundamental
- Price
- HUBC $2.42
- RDHL $2.15
- Analyst Decision
- HUBC
- RDHL
- Analyst Count
- HUBC 0
- RDHL 0
- Target Price
- HUBC N/A
- RDHL N/A
- AVG Volume (30 Days)
- HUBC 1.7M
- RDHL 18.4K
- Earning Date
- HUBC 05-01-2025
- RDHL 08-28-2025
- Dividend Yield
- HUBC N/A
- RDHL N/A
- EPS Growth
- HUBC N/A
- RDHL N/A
- EPS
- HUBC N/A
- RDHL N/A
- Revenue
- HUBC $29,562,000.00
- RDHL $8,042,999.00
- Revenue This Year
- HUBC N/A
- RDHL $381.91
- Revenue Next Year
- HUBC N/A
- RDHL N/A
- P/E Ratio
- HUBC N/A
- RDHL N/A
- Revenue Growth
- HUBC N/A
- RDHL 23.17
- 52 Week Low
- HUBC $1.72
- RDHL $1.71
- 52 Week High
- HUBC $14.00
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- HUBC 48.64
- RDHL 64.10
- Support Level
- HUBC $1.78
- RDHL $2.00
- Resistance Level
- HUBC $2.18
- RDHL $2.08
- Average True Range (ATR)
- HUBC 0.19
- RDHL 0.09
- MACD
- HUBC 0.03
- RDHL 0.03
- Stochastic Oscillator
- HUBC 54.29
- RDHL 100.00
About HUBC Hub Cyber Security Ltd.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.